With a deeper understanding of the molecular mechanisms of the disease and the discovery of different subtypes of prostate cancer, poly (ADP‐ribose) polymerase (PARP) inhibitors, which have emerged in recent years, offer new hope. The gene discussed is PARP1; the disease is prostate cancer.